Delaney Fagan, PA
Medical · Wilmington, DENPI 1205453719
Payments from drug & device makers
What this record shows
7 manufacturers reported payments, led by Edwards Lifesciences at 51.0% of the total. 2025 is the largest year on record at $872, more than ten times the $12 reported in 2022.
Across 18 payments — averaging $65.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$602
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$250
- Kestra Medical Technology Services, Inc.$152
- Boehringer Ingelheim$116
- AstraZeneca$24
- Amgen$23
- plus $12 from 1 others
What the payments were for
- Travel & lodging$58850%
- Food & beverage$59150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 2 | $602 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $250 |
| Kestra Medical Technology Services, Inc. | 7 | $152 |
| Boehringer Ingelheim | 1 | $116 |
| AstraZeneca | 1 | $24 |
| Amgen | 1 | $23 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$116
How this compares
$1,180 in reported general payments places this provider in the 75th percentile of 73 medical providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 28 | $641 |
| Metoprolol Succinate | 20 | $279 |
| Atorvastatin Calcium | 14 | $231 |
| Amlodipine Besylate | 21 | $119 |
| Amoxicillin | 51 | $62 |
Paid to pharmacies, not to this prescriber.
Other medical in Wilmington
- Charla PhoenixWilmington$7K
- Teresina JensenWilmington$7K
- Emily AndersonWilmington$842
- Rebecca LewisWilmington$405
- Ashley KontraWilmington$388
- Emily PanhuiseWilmington$222
- Trevor ThomasWilmington$152
- Marina PeiperWilmington$134
- Louis ArenaWilmington$126
- Katherine KaminskiWilmington$109
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.